Advance Agrolife Q1 FY27: standalone PAT +152% YoY, margins expand as revenue nearly doubles

Advance Agrolife's standalone Q1 FY27 (quarter ended June 30, 2026) showed revenue from operations up 95.9% year-on-year to ₹330.40 Cr (₹168.61 Cr in Q1 FY26), with net profit up 152.2% YoY to ₹22.55 Cr (₹8.94 Cr) and EPS of ₹3.50 versus ₹1.99. No exceptional items feature in either period, so the YoY jump is fully organic — profit growth outpacing revenue growth lifted net margin to 6.82% from 5.30% a year ago, and operating margin (EBITDA/revenue) to 10.61% from 10.14%. Sequentially the numbers look even sharper — revenue up 166.7% and PAT up 202.2% over Q4 FY26 (₹123.88 Cr revenue, ₹7.46 Cr PAT) — but the company's own filing notes that its business is seasonal, tied to weather and cropping patterns; Q1 (April-June) captures the kharif-season buying window for agrochemicals, so a large QoQ jump against a seasonally soft Q4 (Jan-Mar) is expected rather than a signal of accelerating demand. Sequential OPM actually eased slightly, from 10.80% in Q4 FY26 to 10.61% this quarter, even as it expanded YoY — a margin-trajectory marker worth tracking rather than reading the QoQ jump in isolation. No analyst consensus or brokerage preview for this stock turned up in a web search — it is a recently listed, small-cap, single-segment ("Agro Chemicals") name, and neither our records nor public sources carry a formal management guidance figure, so vsGuidance and vsStreet are both unknown. The filing carries no separate management press release beyond the standard exchange disclosure. Alongside the results, the board also approved the appointment of an additional independent director, the re-designation of an executive director to whole-time director, and the FY26 annual report and AGM notice — none of which bear on this quarter's numbers. Only the standalone results were filed this quarter; no consolidated statement was presented.